Skanska has signed an additional contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA.
STOCKHOLM, Oct. 4, 2023 /PRNewswire/ -- Skanska has signed an additional contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA. The additional contract is worth USD 85M, about SEK 900M, which will be included in the US order bookings for the third quarter 2023.
The five-story building on the Cooperman Barnabas Medical Center campus, totaling 13,000 square meters will provide outpatient cancer treatment. A parking garage will also be constructed.
Construction started in September 2022, and completion is scheduled towards the end of 2025.
For further information please contact:
Chris Mckniff, Communications Director, Skanska USA, tel +1 (347) 409 2719
Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94
Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found at www.skanska.com.
The following files are available for download:
20231004 US cancer center ENG | |
https://news.cision.com/skanska/i/rwjbarnabas-rendering---image-cred-fca-architects,c3222161 | RWJBarnabas Rendering - image cred FCA Architects |
View original content:https://www.prnewswire.com/news-releases/skanska-signs-an-additional-contract-for-cancer-center-in-livingston-new-jersey-usa-for-usd-85m-about-sek-900m-301946656.html
SOURCE Skanska
Company Codes: Bloomberg:SKAB@SS, ISIN:SE0000113250, RICS:SKAB.ST, Stockholm:SKAB, OTC-PINK:SKBSY